HPV gene therapy (Chiron Viagene)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHPV gene therapy (Chiron Viagene)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineCell and gene therapy > Gene therapyVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsUterine Cervical NeoplasmsPapillomavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesChiron Viagene Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesChiron Viagene Inc

Active IndicationsN/A

Inactive IndicationsUterine Cervical NeoplasmsPapillomavirus Infections

Other Information

ATC CodeN/A